The latest updates of ReCre8 all-comers RCT with short DAPT

WE ARE ALVIMEDICA

WORLD LEADING QUALITY

LIVING INNOVATION

BETTER OUTCOMES FOR PATIENTS

The Cre8 excellent Safety and Efficacy has been tested in true real-world patients, including the most complex ones. The most challenging subgroup of patients, HBR and diabetics, have been discussed during the latest Digital JIM 2021. Discover more details!
News

A global manufacturer of unique interventional medical devices, harnessing the power of innovation to improve our patient’s quality of life. We tackle today’s toughest patients clinical conditions by creating innovative products.
About

We create the highest quality products, trusted by leading professionals around the world.
Quality

Our driving passion is to improve the quality of life through innovative technology, creating a better future by investing in both clinical research and product development.
Products

Alvimedica is committed to improving patient outcomes, as well as tackling global issues such as Diabetes, which we are 100% committed to defeating.
Products

PRODUCTS

DIABETES

WORKING FOR
DIABETES
PROJECTS

Diabetes is a number of diseases that involve
problems with hormone insulin.
Normally...

NEWS

Alvimedica @ JIM 2021: “The latest updates of ReCre8 all-comers RCT with short DAPT”

Alvimedica @ LINC 2021: “ILLUMINA Study 2 years results: latest updates”

Alvimedica at the e-Euro PCR 2020: “Latest insights from the ReCre8 randomized trial"

DISCOVER